Skip to main content

Degenerative and Metabolic Brain Diseases

  • Chapter
  • First Online:
Keeling's Fetal and Neonatal Pathology
  • 1399 Accesses

Abstract

Neurodegenerative diseases are rare in childhood. Most of them result from disturbances in the metabolism of energy, lipids, amino acids or metals. Symptoms may not appear before childhood or adolescence, but some are fatal in utero or in the neonatal period; they form the core of this overview. Before starting a postmortem examination, clinical and radiological findings should be obtained, because they may yield important diagnostic clues. Neuropathologically, a useful starting point is to establish whether the gray or the white matter is primarily affected. Microscopically, the neuropathological features can be diagnostic for a certain disease, but in most cases additional biochemical, genetic and molecular studies are required to come to a final diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Wong V. Neurodegenerative diseases in children. Hong Kong Med J. 1997;3:89–95.

    CAS  PubMed  Google Scholar 

  2. Pierre G. Neurodegenerative disorders and metabolic disease. Arch Dis Child. 2013;98:618–24.

    Article  PubMed  Google Scholar 

  3. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia, PA: Saunders/Elsevier; 2008.

    Google Scholar 

  4. Verity C, Winstone AM, Stellitano L, Will R, Nicoll A. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child. 2010;95:361–4.

    Article  PubMed  Google Scholar 

  5. Maroun LL, Graem N. Autopsy standards of body parameters and fresh organ weights in nonmacerated and macerated human fetuses. Pediatr Dev Pathol. 2005;8:204–17.

    Article  PubMed  Google Scholar 

  6. Friede RL. Developmental neuropathology. Berlin: Springer; 1989.

    Book  Google Scholar 

  7. Folkerth RD, Lidov HGW. Congenital malformations, perinatal diseases, and phacomatoses. In: Prayson RA, editor. Neuropathology. 2nd ed. Philadelphia: Elsevier Saunders; 2012. p. 96–182.

    Google Scholar 

  8. Dawson TP, Neal JW, Llewellyn L, Thomas C. Neuropathology techniques. London: Hodder Arnold; 2003.

    Google Scholar 

  9. Ellison D, Love S, Chimelli L, Harding BN. Neuropathology: a reference text of CNS pathology. 3rd ed. London: Elsevier/Mosby; 2013.

    Google Scholar 

  10. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–54.

    Article  CAS  PubMed  Google Scholar 

  11. Okada S, O’Brien JS. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science. 1969;165:698–700.

    Article  CAS  PubMed  Google Scholar 

  12. Suzuki K, Suzuki K. Lysosomal diseases. In: Love S, Louis DN, Ellison DW, editors. Greenfield’s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 515–99.

    Google Scholar 

  13. Charrow J. Ashkenazi Jewish genetic disorders. Familial Cancer. 2004;3:201–6.

    Article  CAS  PubMed  Google Scholar 

  14. Smith NJ, Winstone AM, Stellitano L, Cox TM, Verity CM. GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed. Dev Med Child Neurol. 2012;54:176–82.

    Article  PubMed  Google Scholar 

  15. Purpura DP, Suzuki K. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 1976;116:1–21.

    Article  CAS  PubMed  Google Scholar 

  16. Purpura DP. Ectopic dendritic growth in mature pyramidal neurones in human ganglioside storage disease. Nature. 1978;276:520–1.

    Article  CAS  PubMed  Google Scholar 

  17. Walkley SU, Pierok AL. Ferric ion-ferrocyanide staining in ganglioside storage disease establishes that meganeurites are of axon hillock origin and distinct from axonal spheroids. Brain Res. 1986;382:379–86.

    Article  CAS  PubMed  Google Scholar 

  18. Haltia M. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003;62:1–13.

    Article  PubMed  Google Scholar 

  19. Haltia M. The neuronal ceroid-lipofuscinoses: from past to present. Biochim Biophys Acta. 1762;2006:850–6.

    Google Scholar 

  20. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129:1438–45.

    Article  PubMed  Google Scholar 

  21. Anderson GW, Goebel HH, Simonati A. Human pathology in NCL. Biochim Biophys Acta. 1832;2013:1807–26.

    Google Scholar 

  22. Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis. 2007;30:654–63.

    Article  CAS  PubMed  Google Scholar 

  23. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–31.

    Article  CAS  PubMed  Google Scholar 

  24. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–301.

    Article  CAS  PubMed  Google Scholar 

  25. Chen M, Wang J. Gaucher disease: review of the literature. Arch Pathol Lab Med. 2008;132:851–3.

    Article  PubMed  Google Scholar 

  26. Stone DL, van Diggelen OP, de Klerk JB, Gaillard JL, Niermeijer MF, Willemsen R, et al. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease? Eur J Hum Genet. 1999;7:505–9.

    Article  CAS  PubMed  Google Scholar 

  27. Stone DL, Carey WF, Christodoulou J, Sillence D, Nelson P, Callahan M, et al. Type 2 Gaucher disease: the collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed. 2000;82:F163–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sidransky E, Tayebi N, Stubblefield BK, Eliason W, Klineburgess A, Pizzolato GP, et al. The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. J Med Genet. 1996;33:132–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Harding BN, Egger J, Portmann B, Erdohazi M. Progressive neuronal degeneration of childhood with liver disease. A pathological study. Brain. 1986;109:181–206.

    Article  PubMed  Google Scholar 

  30. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol. 1990;5:273–87.

    Article  CAS  PubMed  Google Scholar 

  31. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol. 2004;55:706–12.

    Article  CAS  PubMed  Google Scholar 

  32. Harding BN, Surtees RAH. Metabolic and neurodegenerative diseases of childhood. In: Love S, Louis DN, Ellison DW, editors. Greenfield’s neuropathology. 8th ed. London: Hodder Arnold; 2008. p. 481–514.

    Google Scholar 

  33. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 1993;3:7–13.

    Article  CAS  PubMed  Google Scholar 

  34. Menkes JH. Kinky hair disease: twenty five years later. Brain Dev. 1988;10:77–9.

    Article  CAS  PubMed  Google Scholar 

  35. Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: classification, diagnosis, and treatment. Neurologist. 2009;15:319–28.

    Article  PubMed  Google Scholar 

  36. Cheon JE, Kim IO, Hwang YS, Kim KJ, Wang KC, Cho BK, et al. Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics. 2002;22:461–76.

    Article  PubMed  Google Scholar 

  37. Kinney HC, Brody BA, Kloman AS, Gilles FH. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol. 1988;47:217–34.

    Article  CAS  PubMed  Google Scholar 

  38. Matalon R, Michals K, Kaul R. Canavan disease: from spongy degeneration to molecular analysis. J Pediatr. 1995;127:511–7.

    Article  CAS  PubMed  Google Scholar 

  39. Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N'Guyen S, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet. 2001;69:1134–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kobayashi T, Goto I, Yamanaka T, Suzuki Y, Nakano T, Suzuki K. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine. Ann Neurol. 1988;24:517–22.

    Article  CAS  PubMed  Google Scholar 

  41. Sahai I, Baris H, Kimonis V, Levy HL. Krabbe disease: severe neonatal presentation with a family history of multiple sclerosis. J Child Neurol. 2005;20:826–8.

    Article  PubMed  Google Scholar 

  42. Wolf NI, Sistermans EA, Cundall M, Hobson GM, Davis-Williams AP, Palmer R, et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain. 2005;128:743–51.

    Article  PubMed  Google Scholar 

  43. Koeppen AH, Robitaille Y. Pelizaeus-Merzbacher disease. J Neuropathol Exp Neurol. 2002;61:747–59.

    Article  PubMed  Google Scholar 

  44. Scheffer IE, Baraitser M, Wilson J, Harding B, Kendall B, Brett EM. Pelizaeus-Merzbacher disease: classical or connatal? Neuropediatrics. 1991;22:71–8.

    Article  CAS  PubMed  Google Scholar 

  45. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656–68.

    Article  CAS  PubMed  Google Scholar 

  46. Zeviani M, Di Donato S. Mitochondrial disorders. Brain. 2004;127:2153–72.

    Article  PubMed  Google Scholar 

  47. Brown GK, Squier MV. Neuropathology and pathogenesis of mitochondrial diseases. J Inherit Metab Dis. 1996;19:553–72.

    Article  CAS  PubMed  Google Scholar 

  48. Volpe JJ, Adams RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol. 1972;20:175–98.

    Article  CAS  PubMed  Google Scholar 

  49. Evrard P, Caviness VS Jr, Prats-Vinas J, Lyon G. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis. Acta Neuropathol. 1978;41:109–17.

    Article  CAS  PubMed  Google Scholar 

  50. Feigin I, Kim HS. Subacute necrotizing encephalomyelopathy in a neonatal infant. J Neuropathol Exp Neurol. 1977;36:364–72.

    Article  CAS  PubMed  Google Scholar 

  51. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008;39:223–35.

    Article  PubMed  Google Scholar 

  52. Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79:190–203.

    Article  PubMed  Google Scholar 

  53. Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. J Neuropathol Exp Neurol. 2015;74:482–92.

    Article  CAS  PubMed  Google Scholar 

  54. Pirot N, Crahes M, Adle-Biassette H, Soares A, Bucourt M, Boutron A, et al. Phenotypic and neuropathological characterization of fetal pyruvate dehydrogenase deficiency. J Neuropathol Exp Neurol. 2016;75:227–38.

    Article  CAS  PubMed  Google Scholar 

  55. Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res. 2002;52:618–24.

    Article  PubMed  Google Scholar 

  56. Freeze HH. Congenital disorders of glycosylation: CDG-I, CDG-II, and beyond. Curr Mol Med. 2007;7:389–96.

    Article  CAS  PubMed  Google Scholar 

  57. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr. 2003;162:359–79.

    Article  CAS  PubMed  Google Scholar 

  58. Martin JJ, Schlote W. Central nervous system lesions in disorders of amino-acid metabolism. A neuropathological study. J Neurol Sci. 1972;15:49–76.

    Article  CAS  PubMed  Google Scholar 

  59. Kolodny EH. Agenesis of the corpus callosum: a marker for inherited metabolic disease? Neurology. 1989;39:847–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Jansen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jansen, C. (2022). Degenerative and Metabolic Brain Diseases. In: Khong, T.Y., Malcomson, R.D.G. (eds) Keeling's Fetal and Neonatal Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-84168-3_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-84168-3_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-84167-6

  • Online ISBN: 978-3-030-84168-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics